The use of mHealth apps to address the HIV prevention and treatment needs of sexual and gender minorities

Ann Arbor MI 02-21-2019 02-21-2019 Dr. Horvath is associate professor in the Division of Epidemiology and Community Health in the School of Public Health at the University of Minnesota. Trained as a clinical psychologist, his research focuses on developing and testing mHealth solutions addressing the HIV prevention and treatment needs of sexual and gender diverse persons. Much of his intervention program focuses on ways to enable and promote peer support as a way to address mental health and substance use among high-risk groups. Dr. Horvath currently has four funded mHealth intervention trials, ranging from a pilot intervention to increase PrEP adherence and engagement in PreP care among young sexual minority men to a large efficacy trial of a stepped care intervention to reduce HIV risk and promote PrEP uptake among transgender and non-binary youth. In this talk, he looks forward to sharing his perspective on the current and future state of mHealth in HIV.

A talk by Dr. Keith Hovarth, University of Minnesota

February 21, 2019
3:30 pm - 5:00 pm
Room 2000, 426 North Ingalls St. (School of Nursing)
Sponsored by: The Center for Sexuality and Health Disparities
Contact Information: Greg Sallabnk - gsall@umich.edu - 734 7635175

More Information >>

Dr. Horvath is associate professor in the Division of Epidemiology and Community Health in the School of Public Health at the University of Minnesota. Trained as a clinical psychologist, his research focuses on developing and testing mHealth solutions addressing the HIV prevention and treatment needs of sexual and gender diverse persons. Much of his intervention program focuses on ways to enable and promote peer support as a way to address mental health and substance use among high-risk groups. Dr. Horvath currently has four funded mHealth intervention trials, ranging from a pilot intervention to increase PrEP adherence and engagement in PreP care among young sexual minority men to a large efficacy trial of a stepped care intervention to reduce HIV risk and promote PrEP uptake among transgender and non-binary youth. In this talk, he looks forward to sharing his perspective on the current and future state of mHealth in HIV.